Examination of clinical data linking calorie-reduction weight-loss treatments to changes in epigenetic aging and visceral fat–related risk markers.
Key Takeaways
- Trial analyzed 108 adults with HIV-associated abdominal fat randomized to active or placebo injections
- Treatment slowed biological aging pace by 9% as measured by DunedinPACE
- Epigenetic clocks tied to inflammation and multiple organ risks also showed significant slowing